Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
SoundHound AI
SOUN
5
Super Micro Computer
SMCI
US Stock MarketDetailed Quotes
CGEM Cullinan Therapeutics
- 8.490
- -0.120-1.39%
Close Feb 28 16:00 ET
- 8.500
- +0.010+0.12%
Post 18:52 ET
496.77MMarket Cap-3.05P/E (TTM)
8.680High8.290Low725.81KVolume8.650Open8.610Pre Close6.14MTurnover1.86%Turnover RatioLossP/E (Static)58.51MShares30.18952wk High0.84P/B331.44MFloat Cap8.29052wk Low--Dividend TTM39.04MShs Float59.850Historical High--Div YieldTTM4.53%Amplitude7.300Historical Low8.463Avg Price1Lot Size
Cullinan Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -8.21%-145.3M | -102.01%-36.63M | 0.01%-34.14M | -17.05%-36.29M | 25.00%-38.25M | -6.01%-134.28M | 27.43%-18.13M | 37.19%-34.14M | -21.97%-31.01M | -132.78%-51M |
| Net income from continuing operations | -8.04%-167.58M | -86.39%-47.65M | -3.51%-40.56M | -30.47%-42.03M | 35.78%-37.34M | -242.04%-155.1M | 5.63%-25.56M | -57.42%-39.18M | -118.51%-32.21M | -350.99%-58.14M |
| Depreciation and amortization | -1.29%306K | 0.00%77K | -5.00%76K | -4.94%77K | 5.56%76K | 233.33%310K | 30.51%77K | 788.89%80K | 575.00%81K | 453.85%72K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | -64.97%131K | -45.96%127K | --0 | --0 | --4K |
| Change In working capital | -14.75%-389K | 45.65%4.82M | 1,117.68%1.84M | 75.30%-1.15M | -600.34%-5.9M | -103.03%-339K | 166.05%3.31M | 99.48%-181K | -109.67%-4.65M | -61.03%1.18M |
| -Change in prepaid assets | 58.41%-2.47M | 50.36%-1.64M | 135.27%1.34M | -235.28%-2.59M | 154.44%411K | -426.02%-5.94M | -428.73%-3.29M | -801.84%-3.81M | 2,028.89%1.92M | 33.77%-755K |
| -Change in payables and accrued expense | -62.84%2.08M | -2.24%6.46M | -86.28%498K | 122.00%1.44M | -426.36%-6.32M | -54.45%5.61M | 250.50%6.6M | 110.24%3.63M | -113.68%-6.56M | -53.57%1.94M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -8.21%-145.3M | -102.01%-36.63M | 0.01%-34.14M | -17.05%-36.29M | 25.00%-38.25M | -6.01%-134.28M | 27.43%-18.13M | 37.19%-34.14M | -21.97%-31.01M | -132.78%-51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -480.70%-136.31M | -68.98%15.96M | 146.27%19.88M | -1,628.59%-185.11M | -14.67%12.96M | -85.62%35.81M | 279.90%51.47M | 25.91%-42.96M | -95.97%12.11M | -56.26%15.18M |
| Net PPE purchase and sale | --0 | --0 | --0 | --0 | --0 | 80.04%-208K | --0 | --0 | ---49K | ---159K |
| Net investment purchase and sale | -478.50%-136.31M | -68.98%15.96M | 146.27%19.88M | -1,622.43%-185.11M | -15.56%12.96M | 244.15%36.01M | 285.02%51.47M | 31.52%-42.96M | -60.59%12.16M | -55.80%15.34M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -480.70%-136.31M | -68.98%15.96M | 146.27%19.88M | -1,628.59%-185.11M | -14.67%12.96M | -85.62%35.81M | 279.90%51.47M | 25.91%-42.96M | -95.97%12.11M | -56.26%15.18M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 553.21%266.19M | 537.90%1.58M | 1,083.04%1.33M | 579.23%262.2M | -39.35%1.09M | 257.14%40.75M | 100.75%248K | -92.14%112K | 1,817.64%38.6M | -49.48%1.79M |
| Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | 942.86%1.83M | --0 | --0 | --0 | 128.13%1.83M |
| Net common stock issuance | 584.20%262.65M | --0 | --0 | ---- | ---- | --38.39M | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | 1,384.01%7.98M | 537.90%1.58M | 1,668.75%1.98M | 1,458.88%3.34M | 3,113.89%1.09M | -91.06%538K | 27.84%248K | -92.14%112K | -92.39%214K | -102.27%-36K |
| Net other financing activities | ---4.45M | --0 | ---656K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 553.21%266.19M | 537.90%1.58M | 1,083.04%1.33M | 579.23%262.2M | -39.35%1.09M | 257.14%40.75M | 100.75%248K | -92.14%112K | 1,817.64%38.6M | -49.48%1.79M |
| Net cash flow | ||||||||||
| Beginning cash position | -36.96%98.43M | 57.42%102.09M | -18.90%115.02M | -39.22%74.23M | -36.96%98.43M | 161.24%156.15M | -73.28%64.85M | -59.88%141.83M | 60.45%122.13M | 161.24%156.15M |
| Current changes in cash | 73.27%-15.43M | -156.81%-19.08M | 83.20%-12.94M | 107.01%40.79M | 28.86%-24.21M | -159.89%-57.72M | 138.83%33.59M | 30.58%-76.99M | -92.90%19.71M | -308.17%-34.02M |
| End cash Position | -15.67%83.01M | -15.67%83.01M | 57.42%102.09M | -18.90%115.02M | -39.22%74.23M | -36.96%98.43M | -36.96%98.43M | -73.28%64.85M | -59.88%141.83M | 60.45%122.13M |
| Free cash flow | -8.05%-145.3M | -102.01%-36.63M | 0.01%-34.14M | -16.86%-36.29M | 25.23%-38.25M | -5.23%-134.48M | 29.90%-18.13M | 37.48%-34.14M | -22.17%-31.06M | -133.50%-51.16M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |